Santos da Silva Jorge — SEC Form 4 filings
SEC reporting owner CIK 1920509. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-13.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-20 to 2026-07-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 7 filings — 684,740 shares, $19,150,624 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: sale of 62,810 shares @ $55.00 ($3,454,550) in MoonLake Immunotherapeutics, filed 2024-02-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer, Director | 10 | — | 14 legs · 684,740 sh · $19,150,624 | 5 |
Form 4 filings — Santos da Silva Jorge
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | MoonLake Immunotherapeutics (MLTX) | Sale (S): 33,936 @ $20.01 · Sale (S): 68,289 @ $20.02 | EDGAR |
| 2026-07-02 | 4 | MoonLake Immunotherapeutics (MLTX) | Sale (S): 47,775 @ $20.03 | EDGAR |
| 2026-04-14 | 4 | MoonLake Immunotherapeutics (MLTX) | Sale (S): 98,127 @ $18.41 · Sale (S): 51,873 @ $18.23 | EDGAR |
| 2026-01-09 | 4 | MoonLake Immunotherapeutics (MLTX) | Grant/award (A): 520,342 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | MoonLake Immunotherapeutics (MLTX) | Conversion (C): 196,316 · Disposition to issuer (D): 196,316 · Conversion (C): 5,836 (derivative) | EDGAR |
| 2025-12-10 | 4 | MoonLake Immunotherapeutics (MLTX) | Sale (S): 130,000 @ $15.08 · Sale (S): 70,000 @ $14.49 | EDGAR |
| 2025-03-03 | 4 | MoonLake Immunotherapeutics (MLTX) | Grant/award (A): 95,763 @ $0 | EDGAR |
| 2024-02-29 | 4 | MoonLake Immunotherapeutics (MLTX) | Sale (S): 62,810 @ $55 · Sale (S): 56,065 @ $55 · Sale (S): 4,740 @ $55.89 | EDGAR |
| 2024-02-23 | 4 | MoonLake Immunotherapeutics (MLTX) | Sale (S): 1,125 @ $55.27 | EDGAR |
| 2024-02-20 | 4 | MoonLake Immunotherapeutics (MLTX) | Sale (S): 20,000 @ $60.18 · Sale (S): 20,000 @ $60.15 · Sale (S): 20,000 @ $57.44 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1920509 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →